Annual Cash & Cash Equivalents
$51.77 M
-$11.97 M-18.77%
31 December 2023
Summary:
Cara Therapeutics annual cash & cash equivalents is currently $51.77 million, with the most recent change of -$11.97 million (-18.77%) on 31 December 2023. During the last 3 years, it has risen by +$20.09 million (+63.42%). CARA annual cash & cash equivalents is now -18.77% below its all-time high of $63.74 million, reached on 31 December 2022.CARA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$37.06 M
-$12.18 M-24.73%
30 September 2024
Summary:
Cara Therapeutics quarterly cash and cash equivalents is currently $37.06 million, with the most recent change of -$12.18 million (-24.73%) on 30 September 2024. Over the past year, it has dropped by -$25.81 million (-41.06%). CARA quarterly cash and cash equivalents is now -66.65% below its all-time high of $111.12 million, reached on 30 September 2015.CARA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.8% | -41.1% |
| 3 y3 years | +63.4% | +61.2% |
| 5 y5 years | +243.3% | +6.8% |
CARA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.8% | +284.9% | -41.9% | +175.5% |
| 5 y | 5 years | -18.8% | +284.9% | -50.8% | +175.5% |
| alltime | all time | -18.8% | +4535.2% | -66.7% | +3217.9% |
Cara Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $37.06 M(-24.7%) |
| June 2024 | - | $49.24 M(+4.8%) |
| Mar 2024 | - | $47.00 M(-9.2%) |
| Dec 2023 | $51.77 M(-18.8%) | $51.77 M(-17.7%) |
| Sept 2023 | - | $62.88 M(+7.9%) |
| June 2023 | - | $58.25 M(+22.9%) |
| Mar 2023 | - | $47.39 M(-25.7%) |
| Dec 2022 | $63.74 M(+373.8%) | $63.74 M(+48.9%) |
| Sept 2022 | - | $42.81 M(-8.4%) |
| June 2022 | - | $46.72 M(+118.7%) |
| Mar 2022 | - | $21.36 M(+58.8%) |
| Dec 2021 | $13.45 M(-57.5%) | $13.45 M(-41.5%) |
| Sept 2021 | - | $22.99 M(+2.9%) |
| June 2021 | - | $22.34 M(-0.8%) |
| Mar 2021 | - | $22.52 M(-28.9%) |
| Dec 2020 | $31.68 M(+73.1%) | $31.68 M(-57.9%) |
| Sept 2020 | - | $75.28 M(+32.1%) |
| June 2020 | - | $56.97 M(+234.4%) |
| Mar 2020 | - | $17.04 M(-6.9%) |
| Dec 2019 | $18.30 M(+21.4%) | $18.30 M(-47.3%) |
| Sept 2019 | - | $34.70 M(+87.7%) |
| June 2019 | - | $18.49 M(+30.3%) |
| Mar 2019 | - | $14.19 M(-5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $15.08 M(+60.6%) | $15.08 M(-84.4%) |
| Sept 2018 | - | $96.73 M(+443.4%) |
| June 2018 | - | $17.80 M(+49.9%) |
| Mar 2018 | - | $11.88 M(+26.5%) |
| Dec 2017 | $9.39 M(-22.4%) | $9.39 M(-20.4%) |
| Sept 2017 | - | $11.79 M(+25.2%) |
| June 2017 | - | $9.42 M(+77.5%) |
| Mar 2017 | - | $5.31 M(-56.1%) |
| Dec 2016 | $12.09 M(-19.9%) | $12.09 M(+122.9%) |
| Sept 2016 | - | $5.43 M(+53.1%) |
| June 2016 | - | $3.54 M(-55.3%) |
| Mar 2016 | - | $7.92 M(-47.5%) |
| Dec 2015 | $15.10 M(-71.3%) | $15.10 M(-86.4%) |
| Sept 2015 | - | $111.12 M(+157.3%) |
| June 2015 | - | $43.19 M(-8.9%) |
| Mar 2015 | - | $47.42 M(-10.0%) |
| Dec 2014 | $52.66 M(+326.2%) | $52.66 M(-9.8%) |
| Sept 2014 | - | $58.39 M(-7.0%) |
| June 2014 | - | $62.81 M(-6.3%) |
| Mar 2014 | - | $67.04 M(+442.5%) |
| Dec 2013 | $12.36 M(+1006.3%) | $12.36 M(-30.3%) |
| Sept 2013 | - | $17.73 M(+1487.6%) |
| Dec 2012 | $1.12 M(-72.7%) | $1.12 M |
| Dec 2011 | $4.10 M | - |
FAQ
- What is Cara Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cara Therapeutics?
- What is Cara Therapeutics annual cash & cash equivalents year-on-year change?
- What is Cara Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cara Therapeutics?
- What is Cara Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Cara Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CARA is $51.77 M
What is the all time high annual cash & cash equivalents for Cara Therapeutics?
Cara Therapeutics all-time high annual cash & cash equivalents is $63.74 M
What is Cara Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CARA annual cash & cash equivalents has changed by -$11.97 M (-18.77%)
What is Cara Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CARA is $37.06 M
What is the all time high quarterly cash and cash equivalents for Cara Therapeutics?
Cara Therapeutics all-time high quarterly cash and cash equivalents is $111.12 M
What is Cara Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CARA quarterly cash and cash equivalents has changed by -$25.81 M (-41.06%)